Diagonal Therapeutics is a startup based in the United States, most recent round Series B, 2 tracked investors.
Diagonal Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series B. Brouky records 2 investors associated with the company.
Diagonal Therapeutics develops clustering antibody therapeutics that target dysregulated cellular signaling pathways to modify the underlying causes of genetic and chronic diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.